Overview Efficacy of XP20B Following Bunionectomy Surgery Status: Completed Trial end date: 2008-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery. Phase: Phase 3 Details Lead Sponsor: Xanodyne Pharmaceuticals